wsbdaily | Tue, 20 Dec 2022 03:11:24 EST Where you find Tomorrow’s Hot Stocks Yesterday!
NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
Calithera Biosciences, Inc.(CALA)
Calithera Biosciences, Inc.
343 Oyster Point Boulevard
Suite 200
South San Francisco, CA 94080
United States
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginase inhibitor that has completed Phase 1b clinical t... Read More
Summary & Charts
| Price | $ 2.24 | +0.58 (+34.93%) |
| Day's Range | $ 1.52 - 2.33 | |
| Previous Close | $ 1.66 | |
| Market Cap | $ 16.72M USD | |
| Short Interest % | N/A | |
| Float | N/A | |
| Outstanding | N/A |
| Exchange | NasdaqGS | |
| Industry | Biotechnology | |
| Sector | Healthcare | |
| Volume | 394.00K | |
| Avg. Volume (20 day) | 52.68K | |
| Rel. Volume (20 day) | 7.48 | |
| Rel. Volume (3 month) | 5.76 | |
| Rating | B | Neutral |
| DCF | N/A | Strong Buy |
| Debt/Equity | 40.53 % | Neutral |
| ROE | -507.89 % | Strong Sell |
| ROA | -229.02 % | Sell |
| P/E | -0.08 % | Neutral |
| P/B | 0.41 % | Buy |
| Date | Open | High | Low | Close | Change | Volume | R. Vol. (20d) | R. Vol. (3m) | Mentions |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | $ 1.59 | $ 2.33 | $ 1.52 | $ 2.24 | +0.58 | 393,996 | 7.48 | 5.76 | |
| Dec 15, 2022 | $ 1.37 | $ 1.67 | $ 1.31 | $ 1.66 | +0.27 | 201,262 | 5.79 | 3.26 | |
| Dec 14, 2022 | $ 1.40 | $ 1.41 | $ 1.30 | $ 1.39 | +0.03 | 17,446 | 0.67 | 0.29 | |
| Dec 13, 2022 | $ 1.50 | $ 1.53 | $ 1.33 | $ 1.36 | -0.14 | 49,183 | 1.43 | 0.83 | |
| Dec 12, 2022 | $ 1.54 | $ 1.54 | $ 1.50 | $ 1.50 | -0.05 | 31,776 | 0.95 | 0.54 | |
| Dec 09, 2022 | $ 1.60 | $ 1.66 | $ 1.55 | $ 1.55 | -0.08 | 28,657 | 0.86 | 0.49 | |
| Dec 08, 2022 | $ 1.70 | $ 1.70 | $ 1.62 | $ 1.63 | +0.01 | 13,006 | 0.40 | 0.22 | |
| Dec 07, 2022 | $ 1.80 | $ 1.80 | $ 1.60 | $ 1.62 | -0.19 | 38,021 | 1.15 | 0.63 | |
| Dec 06, 2022 | $ 1.87 | $ 1.91 | $ 1.77 | $ 1.81 | -0.05 | 29,420 | 0.91 | 0.48 | |
| Dec 05, 2022 | $ 1.96 | $ 2.00 | $ 1.85 | $ 1.86 | -0.10 | 41,138 | 1.32 | 0.65 | |
| Dec 02, 2022 | $ 2.00 | $ 2.04 | $ 1.96 | $ 1.96 | -0.06 | 30,857 | 1.03 | 0.49 | |
| Dec 01, 2022 | $ 2.00 | $ 2.05 | $ 1.95 | $ 2.02 | +0.07 | 20,849 | 0.72 | 0.32 | |
| Nov 30, 2022 | $ 1.93 | $ 2.00 | $ 1.92 | $ 1.95 | +0.04 | 16,512 | 0.58 | 0.25 | |
| Nov 29, 2022 | $ 2.01 | $ 2.01 | $ 1.90 | $ 1.91 | +0.00 | 12,602 | 0.45 | 0.19 | |
| Nov 28, 2022 | $ 2.00 | $ 2.02 | $ 1.91 | $ 1.91 | -0.09 | 16,000 | 0.57 | 0.24 | |
| Nov 25, 2022 | $ 2.06 | $ 2.06 | $ 1.96 | $ 2.00 | -0.02 | 4,615 | 0.17 | 0.07 | |
| Nov 23, 2022 | $ 2.03 | $ 2.14 | $ 2.00 | $ 2.02 | -0.04 | 31,021 | 1.08 | 0.45 | |
| Nov 22, 2022 | $ 2.10 | $ 2.13 | $ 1.98 | $ 2.06 | -0.02 | 39,630 | 1.42 | 0.58 | |
| Nov 21, 2022 | $ 2.14 | $ 2.19 | $ 2.02 | $ 2.08 | -0.11 | 25,802 | 0.97 | 0.37 | |
| Nov 18, 2022 | $ 2.13 | $ 2.26 | $ 2.13 | $ 2.19 | +0.08 | 11,786 | 0.44 | 0.17 |
News
The latest news about Calithera Biosciences, Inc. (CALA).
Seeking Alpha | 2022-11-14 22:17:24
Calithera Biosciences, Inc. (NASDAQ:CALA ) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ET Company Participants Stephanie Wong - CFO & Secretary Susan Molineaux - Founder, CEO, President & Director Emil Kuriakose - Chief Medical Officer Conference Call Participants Jiale Song - Jefferies Swayampakula Ramakanth - H.C. Wainwright & Co. Matthew Cowper - SVB Securities Aydin Huseynov - Ladenburg Thalmann Operator Good day, ladies and gentlemen, and thank you for standing by.
GlobeNewsWire | 2022-11-08 16:30:00
SOUTH SAN FRANCISCO, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision-oncology biopharmaceutical company, today announced Company's third quarter 2022 financial results will be released on Monday, November 14, 2022. Company management will host a conference call on Monday, November 14, 2022, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss the financial results and other recent corporate highlights.
Earnings
| Date | Time | EPS Expected | EPS Reported | % | Revenue Expected | Revenue Reported | % |
|---|---|---|---|---|---|---|---|
| 2022-11-14 | AMC | -1.93 | -2.01 | 4.14% | -- | -- | -- |
| 2022-08-15 | AMC | -2.65 | -1.87 | 29.44% | -- | -- | -- |
| 2022-05-10 | AMC | -3.5999999999999996 | -3.60 | -- | -- | -- | -- |
| 2022-03-31 | AMC | -4.8 | -4.80 | -- | -- | -- | -- |
| 2021-11-09 | AMC | -4.6000000000000005 | -3.00 | 34.79% | 9.1M | 6.8M | -25.81% |
| 2021-08-05 | AMC | -4.6000000000000005 | -3.80 | 17.4% | 3.5M | 3M | -14.82% |
| 2021-05-06 | AMC | -5.6000000000000005 | -5.60 | -- | -- | -- | -- |
| 2021-03-16 | AMC | -6.4 | -6.40 | -- | -- | -- | -- |
Top Discussions
These are the top discussions over the last 24-hours that mention the CALA stock ticker symbol.
Failures to Deliver
Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.
Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.
Last Updated: Tue, 14 Dec 2021 12:00 EST
@wsbdaily
wsbdaily